2117 — Cincinnati, Ohio

2117 is a clinical research site located in Cincinnati, Ohio, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

2117 has participated in 1 clinical trials.

Therapeutic areas: Advanced Idiopathic Parkinson's Disease.

Sponsors: UCB BIOSCIENCES GmbH.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 2117?

2117 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 2117 conducted?

2117 has 1 clinical trials on record. Their work covers Advanced Idiopathic Parkinson's Disease.

Is 2117 accredited by Crixeo Health?

2117 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 2117?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.